Skip to main content

Schwarzman Stephen A's Form 4 filing

Medline Inc. (MDLN) · filed Mar 12, 2026

Accession no.
0001193125-26-104180
Filed
Mar 12, 2026, 4:15 PM ET
Trade date
Mar 10, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions. Open-market sales total $1.13B. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schwarzman Stephen ACIK 000107084410% Owner
Blackstone Inc.CIK 000139381810% Owner
Blackstone Group Management L.L.C.CIK 000140407110% Owner
Blackstone Holdings I/II GP L.L.C.CIK 000146469510% Owner
Blackstone Holdings II L.P.CIK 000148487010% Owner
Bma VIII L.L.C.CIK 000208496610% Owner
BCP 8 Holdings Mozart Manager L.L.C.CIK 000209448410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 10, 2026Class A Common StockSSaleDisposed−16,479,083$40.51F1−$667,534,694.16109,250,239IndirectDuplicate filing
Mar 10, 2026Class A Common StockSSaleDisposed−8,241,723$40.51F1−$333,855,715.2810,185IndirectDuplicate filing
Mar 10, 2026Class A Common StockSSaleDisposed−1,886,636$40.51F1−$76,423,851.0912,507,704IndirectDuplicate filing
Mar 10, 2026Class A Common StockSSaleDisposed−1,245,544$40.51F1−$50,454,496.351,539IndirectDuplicate filing
Mar 10, 2026Class A Common StockJOtherDisposed−366,337–F9–2,428,681IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

In connection with the closing of the secondary offering of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), certain of the Reporting Persons sold shares of Class A Common Stock to the underwriters at a price per shares equal to the public offering price of $41.00 per shares of Class A Common Stock, less the underwriting discounts and commissions of $0.492 per share.

Referenced by the price of 4 transactions in Table I.

F9

On March 10, 2026, Mozart Aggregator II LP initiated in-kind distributions of shares of Class A Common Stock to one of its investors and certain affiliated entities of that investor. Such distributees have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among the Reporting Persons and the underwriters.

Referenced by the price of 1 transaction in Table I.

Remarks

Because no more than 10 reporting persons can file any one Form 4 through the Securities and Exchange Commission's EDGAR system, certain affiliates of the Reporting Persons have filed a separate Form 4.

Read the full filing on SEC EDGAR (opens in a new tab)